LYON, France, March 29, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, outlined today the strengthening of its financial profile and the intended use of proceeds from its previously announced registered direct placement of $5.625 million of ordinary shares and warrants, which closed yesterday. The shares were sold in the form of American Depositary Shares ("ADSs") at a price of $2.00 per share, with warrants attached.
